Cadherin 5 Antikörper (PE-Cy7)

Produktnummer ABIN2659098

Dieses Ratte Monoklonal-Antikörper erkennt spezifisch Cadherin 5 in WB, IHC, Neut, ICFC, CyTOF, ELISA (Capture) und ELISPOT (Capture). Er zeigt eine Reaktivität gegenüber Maus.

Kurzübersicht für Cadherin 5 Antikörper (PE-Cy7) (ABIN2659098)

Target: Cadherin 5 (CDH5)

Reaktivität: Maus

Wirt: Ratte

Klonalität: Monoklonal

Konjugat: Dieser Cadherin 5 Antikörper ist konjugiert mit PE-Cy7

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), Neutralization (Neut), Intracellular Flow Cytometry (ICFC), Cytometry by Time of Flight (CyTOF), ELISA (Capture), ELISpot (Capture) (ELISPOT (Capture))

Klon: BV13

Produktdetails anti-Cadherin 5 Antikörper (PE-Cy7)

Aufreinigung: The antibody was purified by affinity chromatography and conjugated with PE/Cy7 under optimal conditions. The solution is free of unconjugated PE/Cy7 and unconjugated antibody.

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 0.2 mg/mL

Buffer: Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Protect from prolonged exposure to light. Do not freeze.

Lagerung: 4 °C

Informationen zur Lagerung: The antibody solution should be stored undiluted between 2°C and 8°C.

Details zu Cadherin 5

Target: Cadherin 5 (CDH5)

Andere Bezeichnung: CD144

Hintergrund: CD144, also known as vascular endothelial-cadherin (VE-cadherin), is a 120 kD member of the type II Cadherin family. It is an endothelial specific hemophilic adhesion molecule involved in endothelial cell survival, migration, contact-dependent growth inhibition, and homophilic adhesion. VE-cadherin is essential for maintaining the integrity of the endothelial barrier in vivo.

Pathways: Cell-Cell Junction Organization, Signaling Events mediated by VEGFR1 and VEGFR2